Skip to main content
Caplight Logo









Redbud Labs

Redbud Labs

Private
Durham, North CarolinaHealthcare & Life Scienceshttps://redbudlabs.com/

Last Round

Grant

Oct 1, 2024

Total Funding Raised

$4.06M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Redbud Labs is a biotechnology company that develops microfluidic components and automated sample preparation platforms for life science research and clinical diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

microfluidicssample preparationlab-on-a-chipnucleic acid extractionautomated sample prepmicrofluidic cartridgesmagnetic bead separationmolecular diagnosticsgenomicsNGSqPCRbiotech equipmentMEMSmicrofluidic mixingbiomanufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Redbud Labs Comparables

Compare Redbud Labs with similar companies based on industry and business-model similarity.

Redbud Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
microfluidic ChipShop
81%
INTEGRA Holding AG
74%
Unchained Labs
74%

Redbud Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 1, 2024
VC RoundJul 17, 2024
GrantNov 7, 2023
VC RoundSep 1, 2021
GrantFeb 7, 2021
Debt
Mar 30, 2019

Key People

Founding team and executive leadership

Ricky Spero

Co-Founder, CEO

Founding Team

Jay Fisher

Chief Scientific Officer, Vice President of Engineering

Executive Team

Redbud Labs Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 36% MoM.

  • May 15, 2026

    Monthly visitors increased 38% MoM, reaching 1.2K.

Redbud Labs Filings

Explore SEC and related filing metadata, where available.

Redbud Labs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Redbud Labs's valuation, stock price, and market status.

Is Redbud Labs a public or private company?

Redbud Labs is a private company.

What is the current stock price of Redbud Labs?

Redbud Labs is a private company with no public stock price. No recent secondary market data is available.

How much is Redbud Labs worth (valuation)?

Valuation information for Redbud Labs is not publicly available.

Can I buy Redbud Labs stock?

Redbud Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Redbud Labs's last funding round?

Redbud Labs's most recent funding round was Grant on October 1, 2024.

Who are the main investors in Redbud Labs?

Key investors in Redbud Labs include NIH RADx, BioTools Innovator, One North Carolina Small Business Program, VentureSouth, National Science Foundation.

Will Redbud Labs IPO soon?

No public IPO plans have been announced for Redbud Labs.

How can I track Redbud Labs secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Redbud Labs's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range24
Year Founded2010
Last FundingOct 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?